This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Evultis Sa. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Alessandro Mazzola: Innovator in Pharmaceutical Processes
Introduction
Alessandro Mazzola is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of non-genotoxic compounds. His work is essential for ensuring the safety and efficacy of pharmaceutical formulations.
Latest Patents
Mazzola holds a patent for a process titled "Process for the preparation of non-genotoxic diacetylrhein (diacerein) and formulations comprising non-genotoxic diacetylrhein." This invention outlines a method for producing non-genotoxic Diacetylrhein, which includes several steps: transforming raw Diacerein into a water-soluble salt, adsorbing the salt solution on a hydrophobic resin, washing to eliminate impurities, and recovering the purified compound. The process ensures that the total content of genotoxic impurities is below 1 ppm, making it suitable for pharmaceutical formulations, including capsules for human and veterinary use.
Career Highlights
Alessandro Mazzola has dedicated his career to advancing pharmaceutical processes. His innovative approach has led to the development of safer compounds that meet the stringent requirements set by health authorities. His expertise in this area has positioned him as a valuable contributor to the pharmaceutical industry.
Collaborations
Mazzola collaborates with Silvia Moiana, working together to enhance the quality and safety of pharmaceutical products. Their partnership exemplifies the importance of teamwork in driving innovation within the industry.
Conclusion
Alessandro Mazzola's contributions to the field of pharmaceuticals through his innovative processes highlight the critical role of inventors in advancing healthcare. His work not only improves the safety of medications but also sets a standard for future developments in the industry.